Author profile

Abdelkhalek Hammi

TU Dortmund University

Presenting AuthorPoster

Modeling Circulating Lymphocyte Dose during Lung Proton Therapy Using AI-Based Pulmonary Vasculature Segmentation and 4D Blood-Flow

Radiation-induced lymphopenia (RiL) is linked to impaired anti-tumor immunity and poorer outcomes in thoracic malignancies. Reducing dose exposure to circulating lymphocytes (CLs) could therefore mitigate RiL. Because Intensity Modulated Proton Therapy (IMPT)...

Poster Program · Therapy Physics

Presenting AuthorPoster

BLUE RIBBON POSTER THERAPY: Dosimetric Comparison of IMRT and VMAT on Circulating Immune Cell Depletion In Glioblastoma Radiotherapy

Radiation-induced lymphopenia (RiL) worsens survival in glioblastoma by impairing anti-tumor immunity. Reducing dose to circulating lymphocytes (CLs) may help mitigate RiL. Because IMRT and VMAT differ in their dynamic delivery time, they may alter blood expo...

Poster Program · Therapy Physics